CN111920909A - Medicine composition for treating cancer - Google Patents

Medicine composition for treating cancer Download PDF

Info

Publication number
CN111920909A
CN111920909A CN202010932961.1A CN202010932961A CN111920909A CN 111920909 A CN111920909 A CN 111920909A CN 202010932961 A CN202010932961 A CN 202010932961A CN 111920909 A CN111920909 A CN 111920909A
Authority
CN
China
Prior art keywords
root
rhizoma
angelica
raw materials
treating cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010932961.1A
Other languages
Chinese (zh)
Inventor
旷甫勇
旷财运
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Fengjie Kuang Fuyong Institute of traditional Chinese Medicine
Original Assignee
Chongqing Fengjie Kuang Fu Yong Institute Of Traditional Chinese Medicine Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Fengjie Kuang Fu Yong Institute Of Traditional Chinese Medicine Co ltd filed Critical Chongqing Fengjie Kuang Fu Yong Institute Of Traditional Chinese Medicine Co ltd
Priority to CN202010932961.1A priority Critical patent/CN111920909A/en
Publication of CN111920909A publication Critical patent/CN111920909A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/648—Myriapods, e.g. centipedes or millipedes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/346—Platycodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/40—Cornaceae (Dogwood family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/41—Crassulaceae (Stonecrop family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/487—Psoralea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489—Sophora, e.g. necklacepod or mamani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718—Coptis (goldthread)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/739—Sanguisorba (burnet)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/744—Gardenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/748—Oldenlandia or Hedyotis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/756—Phellodendron, e.g. corktree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/808—Scrophularia (figwort)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/884—Alismataceae (Water-plantain family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969—Polygonatum (Solomon's seal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A61K36/8988—Gastrodia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994—Coix (Job's tears)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides a prescription for treating cancer, which comprises the following raw materials: leech, scorpion, angelica, donkey-hide gelatin, astragalus root, rhodiola rosea, ground beeltle, nux vomica, liquorice, rhizoma polygonati, medlar, tremella, momordica cochinchinensis, aspongopus, malva verticillata, oyster, gypsum, gardenia, fructus psoraleae, radix rehmanniae, corrugated seed, sword bean, hawthorn, rhizoma atractylodis, tuckahoe, centipede and herba coptidis. The formula of the invention changes the technical means of treating tumor in the original western medicine, does not need chemotherapy, does not implant iodine-125 particles into tumor cancer-killing cells by minimally invasive surgery, and can not control the growth and metastasis of the tumor; the formula of the invention contains six rare traditional Chinese medicines, namely: the contents of cordyceps, saffron, musk, pangolin, antelope horn and pilose antler are the main characteristics of the target, but the six medicines are not used in the invention, thereby reducing the economic value of medicine application and protecting wild animals such as pangolin.

Description

Medicine composition for treating cancer
Technical Field
The invention relates to the field of traditional Chinese medicines, in particular to a medicine formula for treating cancer.
Background
Cancer, also called malignant tumor, is a localized mass formed by abnormal proliferation of cells in local tissues under the action of various tumorigenic factors. Malignant tumors can destroy the structure and function of tissues and organs, causing necrotic hemorrhage with infection, and patients may eventually die due to exhaustion of organ function. The basic unit of cancer lesions is cancer cells, which are caused by gene mutations in normal cells. Normally, most cells of the human body can proliferate, but the proliferation is limited, and the proliferation of cancer cells is endless, so that the nutrients of the physical energy of the patient are greatly consumed. Meanwhile, cancer cells can release various toxins, so that a series of symptoms are produced by a human body. If the cancer cells are found to be untimely and treated, the cancer cells can be transferred to all parts of the body to grow and reproduce, so that the body is thin, weak, anemia, inappetence, fever, seriously damaged organ functions and the like are caused, and severe patients can have symptoms of body weakness, pain or numbness of limbs, reduction of meal, dry mouth and tongue, constipation and the like, so that the patients have no pain and the like. Common cancers include brain cancer, cerebral aneurysm, pituitary tumor, meningioma, cerebral hemangioma, nasal cancer, laryngeal cancer, thyroid cancer, lung adenocarcinoma, pancreatic cancer, lymphoma, bone cancer, breast cancer, liver tumor, etc. Modern medicine is very rare for cancer treatment, and the effective prolongation of the life of patients is considered to be a more effective treatment.
Whether brain cancer, cerebral aneurysm, pituitary gland tumor, meningioma, cerebral hemangioma, nasal cancer, laryngeal cancer, thyroid cancer, lung adenocarcinoma, pancreatic cancer, lymph cancer, bone cancer, breast cancer, liver tumor and the like, the cancer cells are not sensible in the early growth stage of a human, when the human feels and has symptoms, the growth of the cancer cells is in the later stage, and the symptoms of the cancers, such as cold attack, headache, dizziness, cough, sputum spitting and uncomfortable throat, are mostly manifested as chest back pain, severe body weakness, pain or numbness of limbs, hands and feet, reduced amount, dry mouth, rough tongue, constipation and the like, so that the patient is not painful.
When the cancer diseases go to various large tumor hospitals, the treatment means of the western medicine at present adopts chemotherapy, operation, minimally invasive surgery and iodine particle implantation, the medicines are injected into the tumor or lymph node, and the cancer cells are continuously irradiated and killed, but in the processes, doctors and nurses cannot physically contact the medicines, so that the medicines are conceivably harmful to the human body, and the survival rate of the cancer cells and the cancer patients is not high after the medicines enter the human body. Cancer cells have toxic blood to escape everywhere when entering the body, so that the toxic blood is hidden in place and the tumor grows in place after a period of time, which is called the latest cancer metastasis. Once metastasis occurs, western medicine around the world is stranded.
The invention provides a traditional Chinese medicine formula for treating cancer based on the defects of the western medicine in treating cancer, and further changes the unsuccessful technical means of treating cancer in the western medicine; solves the problems that the existing western medicine chemotherapy, minimally invasive surgery, iodine 125 particles implanted into tumor and other cancer cells can not control the growth and metastasis of the tumor.
Disclosure of Invention
The invention aims to provide a medicine formula for treating cancer, which has the effects of strengthening body resistance and building body, clearing away heat and toxic materials, dissipating toxin, resisting cancer and tumors, promoting blood circulation and removing blood stasis, inducing diuresis and excreting dampness and reducing swelling, reducing blood sugar and blood pressure, and reducing blood fat and controlling blood, so that malignant tumors can not grow and transfer.
The technical scheme for realizing the purpose of the invention is as follows: a medicine formula for treating cancer comprises the following raw materials: 450-550 g of leech, 450-550 g of scorpion, 350-450 g of angelica sinensis, 350-450 g of donkey-hide gelatin, 350-450 g of astragalus membranaceus, 350-450 g of rhodiola rosea, 350-450 g of ground beetle, 350-450 g of nux vomica, 250-350 g of liquorice, 250-350 g of rhizoma polygonati, 250-350 g of wolfberry fruit, 250-350 g of tremella, 250-350 g of momordica cochinchinensis, 250-350 g of clam shell, 250-350 g of aspongopus, 250-350 g of cluster mallow seed, 250-350 g of oyster, 250-350 g of gypsum, 250-350 g of gardenia, 150-250 g of fructus psoraleae, 150-250 g of radix rehmanniae, 150-250 g of Concha arcae, 150-250 g of sword bean, 150-250 g of hawthorn, 150-250 g of rhizoma atractylodis, 150-250 g of poria cocos, 100-200 centipedes, 150-250 g of rhizoma gastrodiae and 350.
Further, the medicine also comprises the following medicinal raw materials: 100-200 g of white peony root, 50-150 g of giant knotweed, 50-150 g of field thistle, 150-250 g of garden burnet, 30-130 g of fingered citron, 150-250 g of radix linderae, 30-130 g of cimicifugae foetidae, 50-150 g of kudzu-vine root, 50-150 g of radix stephaniae tetrandrae, 70-170 g of angelica dahurica, 100-200 g of dandelion, 50-150 g of uniflower swisscentaury root, 250-350 g of wild buckwheat rhizome, 150-250 g of herba scutellariae barbatae, 150-250 g of oldenlandia diffusa, 50-150 g of scutellaria baicalensis, 50-150 g of golden cypress.
Further, the medicine also comprises the following medicinal raw materials: 50-150 g of Japanese thistle herb, 100-200 g of figwort root, 50-150 g of cortex moutan, 100-200 g of salvia miltiorrhiza, 50-150 g of herba agrimoniae, 50-150 g of sophora flower, 50-150 g of cacumen biotae, 50-150 g of rhizoma imperatae and 150-250 g of dipsacus root.
Further, the medicine also comprises the following medicinal raw materials: 250-350 g of coix seed, 70-170 g of rhizoma alismatis, 150-250 g of fructus cannabis, 200 g of semen pharbitidis, 50-150 g of eucommia bark, 30-130 g of platycodon grandiflorum and 50-150 g of cornus officinalis.
The medicine is based on that:
1. the main book of the drug selection basis of the invention is as follows: the main codes of 500 ingredients of Lin Zheng Bei Xuan (written in common chapter) and 500 handbooks of Lin Zheng TCM (Zhengting, Jun Ben and Jiawantian).
2. The medicine formula of the invention is a selective medicine for treating tumor regression caused by cancer, is not a unilateral disease medicine, and is a medicine for treating the basic comprehensiveness of the internal organs of the human body. The book selects the medicines of all chapters and sections for clinical evidence investigation of 500 flavors of Chinese medicines. 87 traditional Chinese medicines are selected to form the formula of the invention.
The knowledge of the components and the effects of the traditional Chinese medicine formula and the tumor is as follows:
1. comprises the following components: the traditional Chinese medicine formula of the invention takes the contents of rare medicines as the target: namely cordyceps sinensis (containing amino acid, organic matters, a plurality of vitamins and inorganic elements). Stigma croci (containing crocetin, crocin, vitamins, and amino acids). Moschus (containing muscone, protein, polypeptide, amino acids, and inorganic elements). Squama Manis (containing multiple amino acids and 18 vitamins). Cornu Saigae Tataricae (containing keratin, inorganic salt, 18 amino acids, and polypeptide). Cornu Cervi Pantotrichum (containing various amino acids, microelements, and polypeptide).
2. The traditional Chinese medicine formula disclosed by the invention has the following composition effects: has effects in strengthening body resistance, clearing away heat and toxic materials, removing toxic materials, resisting cancer, resisting tumor, promoting blood circulation, dispelling blood stasis, promoting diuresis, eliminating dampness, relieving swelling, lowering blood sugar and blood pressure, and reducing blood fat.
3. Knowledge of tumors: is a nodule produced in human body due to deficiency, uneven cold and heat, diet discordance with different dietary habits and toxicology of food and drug. Tumors are based on body and blood deficiency, grow in life according to blood and blood fat, grow rapidly according to toxicity as a catalyst, and are rapidly transferred according to blood, blood fat and high-nutrition food.
The medicine formula in the invention is precise in compatibility, and the efficacy and the use value of single medicine are greatly improved through the mutual reinforcement and combined application of the medicines according to the efficacy, the nature and the taste of the medicine, the meridian tropism and the non-toxic effect of the medicine and the treatment principle of the traditional Chinese medicine formula.
The invention mainly uses monarch, minister, adjuvant and drug selection and the compatibility relationship is as follows:
(1) the monarch drug has two ingredients: leech and scorpion contain six medicinal components and have the same effects of resisting blood coagulation, detoxifying, resolving masses, reducing swelling and resisting tumors.
(2) Ministerial drugs: the six medicines have the contents of the six famous medicines and also have the combined action of strengthening the body resistance, strengthening the body and resisting tumors.
(3) Adjuvant drugs: licorice, sealwort, medlar, tremella, momordica seed, clam shell, aspongopus, malva seed, oyster, gypsum, gardenia, malaytea scurfpea fruit, dried rehmannia root, corrugated fern seed, sword bean, hawthorn, rhizoma atractylodis, tuckahoe, centipede and common lopseed, and the adjuvant drugs have six famous drug content components and have the combined action of resisting tumors.
The invention also provides the following innovative drug selection conditions for controlling the tumor:
1. the heat-clearing and detoxifying, toxin-dispersing and antitoxic drugs are selected from: controlling the growth rate of the cancer tumor. Licorice, white peony root, astragalus, rhodiola rosea, sealwort, tiger husband, common cephalanoplos herb, garden burnet root, finger citron, combined spicebush root, rhizoma atractylodis, rhizoma cimicifugae, kudzu-vine root, divaricate saposhnikovia root, dahurian angelica root, dandelion, uniflower swisscentaury root, wild buckwheat rhizome, Chinese lobelia, oldenlandia, centipede, scorpion, gardenia, scutellaria, phellodendron, coptis and.
2. Herbs that can resolve blood stasis, dissipate nodulation, soften and dissipate nodulation, resolve and eliminate stone can degenerate tumor. Clam shell, leech, ground beeltle, Japanese thistle herb, common cephalanoplos herb, nux vomica, momordica cochinchinensis, uniflower swisscentaury root, centipede, oyster, tremella, scorpion, figwort root, tree peony bark, salvia miltiorrhiza and hawthorn.
3. Blood controlling hemostatics, controlling cancer cell metastasis, and limiting blood disorder to form normal rules. Colla Corii Asini, radix Rhodiolae, rhizoma Polygonati, herba Ecliptae, rhizoma Polygoni Cuspidati, herba et Gemma Agrimoniae, herba seu radix Cirsii Japonici, herba Cephalanoploris, radix Sangusorbae, flos Sophorae Immaturus, folium Platycladi, radix Angelicae Dahuricae, lalang grass rhizome, cimicifugae rhizoma, radix rehmanniae, Scutellariae radix, and radix Dipsaci.
4. Herbs that can invigorate spleen, induce diuresis, remove dampness, alleviate edema, moisten intestines, relieve constipation, reduce blood heat and eliminate tumor. Poria, Coicis semen, Alismatis rhizoma, semen Abutili, fructus Cannabis, and semen Pharbitidis.
5. Hypolipidemic agents: blood lipids are a factor in tumor development. Radix Angelicae sinensis, Glycyrrhrizae radix, Eucommiae cortex, rhizoma Polygonati, fructus Lycii, radix Platycodi, Saviae Miltiorrhizae radix, rhizoma Polygoni Cuspidati, Hirudo, flos Sophorae Immaturus, cimicifugae rhizoma, radix Puerariae, radix Rhapontici, Alismatis rhizoma, Scutellariae radix, Corni fructus, and Tremella.
The formula of the invention can also avoid the use of dodder, uncaria, ligusticum wallichii, curcuma zedoary, corydalis tuber, lycopodium clavatum, moutan bark, peucedanum root, stemona root, cynanchum root, brassica alba boiss, corydalis tuber, almond, ephedra, notopterygium root, magnolia flower, dried orange peel, immature bitter orange, costus root, malt, bupleurum and magnolia officinalis as guiding drugs and matched with monarch, minister, adjuvant drugs. The twenty-two medicinal herbs can further assist adjuvant drugs to enhance the treatment effect of the formula. In the invention, the monarch, minister, adjuvant and twenty-nine medicines can play a good role in the invention; the effect of the invention can be further enhanced by matching with conditional drugs and guiding drugs. The prescription of the invention is a selective medicine for treating cancer and tumor and causing tumor regression, not a unilateral disease medicine, and is a medicine for treating the basic comprehensiveness of the internal organs of the human body.
The invention has the beneficial effects that:
1. the formula of the invention changes the technical means of treating tumor in the original western medicine, and the problem that the growth and the metastasis of the tumor cannot be controlled because the iodine-125 particles which are not used for chemotherapy or minimally invasive surgery are implanted into tumor cancer killing cells.
2. The invention has the effects of strengthening body resistance and building body, clearing away heat and toxic materials, dissipating toxin, resisting cancer and tumor, promoting blood circulation and removing blood stasis, inducing diuresis and excreting dampness and reducing swelling, reducing blood sugar and blood pressure, and reducing blood fat and controlling blood.
3. The traditional Chinese medicine formula of the invention applies six rare traditional Chinese medicines, namely: the contents of cordyceps, saffron, musk, pangolin, antelope horn and pilose antler are the main characteristics of the target, but the six medicines are not used in the invention, thereby reducing the economic value of medicine application and protecting wild animals such as pangolin.
4. The following drug selection conditions (1) to (6) for preventing the tumor from growing and transferring are innovated.
(1) Clearing away heat and toxic materials, dispelling toxin, and resisting toxin (controlling growth rate of cancer cells);
(2) reducing and degenerating tumor by removing blood stasis, resolving hard mass, softening and resolving hard mass, dissolving and removing hard mass, resisting blood coagulation and the like;
(3) controlling blood to stop bleeding, limiting disorder caused by recklessly blood flow due to blood heat, and controlling cancer cell metastasis;
(4) invigorating spleen, promoting diuresis, eliminating dampness, relieving constipation, and reducing blood heat to treat tumor;
(5) reducing blood fat, and making tumor lose the main force of life accompanying;
(6) stopping the high-nutrition food and spicy and hot food of cancer patients during taking medicine, allowing pork to be eaten, and reducing the support of tumor growth blood heat) to force tumor to be degenerated.
The medicine of the invention is characterized in that:
1. the invention formula of the traditional Chinese medicine consists of 87 traditional Chinese medicines. The components of the medicine contain the content of the six rare Chinese medicines, and the amount of the components reaches more than half of the total dosage. Has the important functions of strengthening body resistance, strengthening body constitution and resisting cancer.
2. The Chinese medicine condition of the invention applies six conditions of innovative medicine selection and main characteristics, and controls the growth and metastasis of tumors.
3. The traditional Chinese medicine formula of the invention applies six rare traditional Chinese medicines, namely: the main characteristics of the target are the contents of cordyceps sinensis, saffron, musk, pangolin, antelope horn and pilose antler.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the following detailed description is further provided in conjunction with the embodiments.
Example 1
A medicine formula for treating cancer comprises the following raw materials: 450-550 g of leech, 450-550 g of scorpion, 350-450 g of angelica sinensis, 350-450 g of donkey-hide gelatin, 350-450 g of astragalus membranaceus, 350-450 g of rhodiola rosea, 350-450 g of ground beetle, 350-450 g of nux vomica, 250-350 g of liquorice, 250-350 g of rhizoma polygonati, 250-350 g of wolfberry fruit, 250-350 g of tremella, 250-350 g of momordica cochinchinensis, 250-350 g of clam shell, 250-350 g of aspongopus, 250-350 g of cluster mallow seed, 250-350 g of oyster, 250-350 g of gypsum, 250-350 g of gardenia, 150-250 g of fructus psoraleae, 150-250 g of radix rehmanniae, 150-250 g of Concha arcae, 150-250 g of sword bean, 150-250 g of hawthorn, 150-250 g of rhizoma atractylodis, 150-250 g of poria cocos, 100-200 centipedes, 150-250 g of rhizoma gastrodiae and 350.
Example 2
A medicine formula for treating cancer comprises the following raw materials: 100-200 g of white peony root, 50-150 g of giant knotweed, 50-150 g of field thistle, 150-250 g of garden burnet, 30-130 g of fingered citron, 150-250 g of radix linderae, 30-130 g of cimicifugae foetidae, 50-150 g of kudzu-vine root, 50-150 g of radix stephaniae tetrandrae, 70-170 g of angelica dahurica, 100-200 g of dandelion, 50-150 g of uniflower swisscentaury root, 250-350 g of wild buckwheat rhizome, 150-250 g of herba scutellariae barbatae, 150-250 g of oldenlandia diffusa, 50-150 g of scutellaria baicalensis, 50-150 g of golden cypress.
Example 3
A medicine formula for treating cancer comprises the following raw materials: 50-150 g of Japanese thistle herb, 100-200 g of figwort root, 50-150 g of cortex moutan, 100-200 g of salvia miltiorrhiza, 50-150 g of herba agrimoniae, 50-150 g of sophora flower, 50-150 g of cacumen biotae, 50-150 g of rhizoma imperatae and 150-250 g of dipsacus root.
Example 4
A medicine formula for treating cancer comprises the following raw materials: 250-350 g of coix seed, 70-170 g of rhizoma alismatis, 150-250 g of fructus cannabis, 200 g of semen pharbitidis, 50-150 g of eucommia bark, 30-130 g of platycodon grandiflorum and 50-150 g of cornus officinalis.
Example 5
A medicine formula for treating cancer comprises the following raw materials: 100-200 g of semen cuscutae, 50-150 g of uncaria, 50-150 g of ligusticum wallichii, 150-250 g of curcuma zedoary, 150-250 g of rhizoma corydalis, 150-250 g of lycopodium clavatum, 50-150 g of moutan bark, 50-150 g of radix peucedani, 50-150 g of radix stemonae, 50-150 g of cynanchum glaucescens, 30-130 g of semen brassicae, 150-250 g of corydalis tuber, 50-150 g of almond, 30-130 g of ephedra, 50-150 g of notopterygium root, 50-150 g of biond magnolia flower, 30-130 g of dried orange peel, 30-130 g of immature bitter orange, 30-130 g of costus root, 250-350 g of malt, 50-150 g of radix bupleuri and 150-250 g.
The invention can also avoid dodder, uncaria, ligusticum wallichii, curcuma zedoary, corydalis tuber, lycopodium clavatum, moutan bark, peucedanum root, stemona root, cynanchum glaucescens, brassica alba boiss, corydalis tuber, almond, ephedra, notopterygium root, biond magnolia flower, dried orange peel, immature bitter orange, costus root, malt, radix bupleuri and mangnolia officinalis as guiding medicaments, and the twenty-two guiding medicaments can be adopted to further assist adjuvant medicaments, thereby enhancing the treatment effect of the formula of the invention.
Example 6
A medicine formula for treating cancer comprises the following raw materials: 450-550 g of leech, 450-550 g of scorpion, 350-450 g of angelica sinensis, 350-450 g of donkey-hide gelatin, 350-450 g of astragalus membranaceus, 350-450 g of rhodiola rosea, 350-450 g of ground beetle, 350-450 g of nux vomica, 250-350 g of liquorice, 250-350 g of rhizoma polygonati, 250-350 g of wolfberry fruit, 250-350 g of tremella, 250-350 g of momordica cochinchinensis, 250-350 g of clam shell, 250-350 g of aspongopus, 250-350 g of cluster mallow, 250-350 g of oyster, 250-350 g of gypsum, 250-350 g of gardenia, 150-250 g of fructus psoraleae, 150-250 g of radix rehmanniae, 150-250 g of tile fern, 150-250 g of sword bean, 150-250 g of hawthorn, 150-250 g of rhizoma atractylodis, 150-250 g of poria cocos, 100-200 centipedes, 150-250 g of hemibarleflower, 350-450 g of garden burnet, 100-200 g of white peony root, 50-150 g of polygonum cuspidatum, 50-150 g of field thistle, 150 g of rhizoma, 50-150 g of kudzu root, 50-150 g of radix stephaniae tetrandrae, 70-170 g of angelica dahurica, 100-200 g of dandelion, 50-150 g of uniflower swisscentaury root, 250-350 g of wild buckwheat rhizome, 150-250 g of herba scutellariae barbatae, 150-250 g of spreading hedyotis herb, 50-150 g of scutellaria baicalensis, 50-150 g of phellodendron bark, 50-150 g of coptis chinensis, 50-150 g of schisandra chinensis, 50-150 g of Japanese thistle herb, 100-200 g of figwort root, 50-150 g of cortex moutan, 100-200 g of salvia miltiorrhiza, 50-150 g of eclipta alba, 250-350 g of hairyvein agrimony, 50-150 g of sophora flower, 50-150 g of cacumen biotae, 50-150 g of hairy root, 150-250 g of dipsacus root, 250-350 g of semen coicis, 70-170 g of rhizoma alismatis, 150-250 g of fructus cannabis, 200 g of semen pharbitidis, 50-150 g of eucommia bark, 30-130 g of platycodon grandiflorum, 50-150 g of cornus, 100-200 g of semen cuscutae, 50-200 g, 50-150 g of moutan bark, 50-150 g of whiteflower hogfennel root, 50-150 g of stemona root, 50-150 g of cynanchum glaucescens, 30-130 g of semen brassicae, 150-250 g of corydalis tuber, 50-150 g of almond, 30-130 g of ephedra, 50-150 g of notopterygium root, 50-150 g of biond magnolia flower, 30-130 g of dried orange peel, 30-130 g of immature bitter orange, 30-130 g of costus root, 250-350 g of malt, 50-150 g of radix bupleuri and 150-250 g of mangnolia officinalis.
Example 7
A medicine formula for treating cancer comprises the following raw materials: 450 g of leech, 450 g of scorpion, 350 g of angelica, 350 g of donkey-hide gelatin, 350 g of astragalus, 350 g of rhodiola rosea, 350 g of ground beetle, 350 g of nux vomica, 250 g of liquorice, 250 g of rhizoma polygonati, 250 g of medlar, 250 g of tremella, 250 g of momordica cochinensis, 250 g of clam shell, 250 g of aspongopus, 250 g of chingma abutilon seed, 250 g of oyster, 250 g of gypsum, 250 g of gardenia, 150 g of fructus psoraleae, 150 g of radix rehmanniae, 150 g of concha arcae, 150 g of sword bean, 150 g of hawthorn, 150 g of rhizoma atractylodis, 150 g of poria cocos, 100 centipedes, 150 g of rhizoma gastrodiae and.
Example 8
A medicine formula for treating cancer comprises the following raw materials: 500 g of leech, 500 g of scorpion, 400 g of angelica, 400 g of donkey-hide gelatin, 400 g of astragalus, 400 g of rhodiola rosea, 400 g of ground beetle, 400 g of nux vomica, 300 g of liquorice, 300 g of rhizoma polygonati, 300 g of medlar, 300 g of tremella, 300 g of momordica cochinensis, 300 g of clam shell, 300 g of aspongopus, 300 g of malva verticillata, 300 g of oyster, 300 g of gypsum, 300 g of gardenia, 200 g of fructus psoraleae, 200 g of radix rehmanniae, 200 g of concha arcae, 200 g of sword bean, 200 g of hawthorn, 200 g of rhizoma atractylodis, 200 g of poria cocos, 150 centipedes, 200 g of rhizoma gastrodiae and 400 g.
Example 9
A medicine formula for treating cancer comprises the following raw materials: 550 g of leech, 550 g of scorpion, 450 g of angelica, 450 g of donkey-hide gelatin, 450 g of astragalus, 450 g of rhodiola rosea, 450 g of ground beetle, 450 g of nux vomica, 350 g of liquorice, 350 g of rhizoma polygonati, 350 g of medlar, 350 g of tremella, 350 g of momordica cochinensis, 350 g of clam shell, 350 g of aspongopus, 350 g of chingma abutilon seed, 350 g of oyster, 350 g of gypsum, 350 g of gardenia, 250 g of fructus psoraleae, 250 g of radix rehmanniae, 250 g of concha arcae, 250 g of sword bean, 250 g of hawthorn, 250 g of rhizoma atractylodis, 250 g of poria cocos, 200 centipedes, 250 g of rhizoma gastrodiae and.
Example 10
A medicine formula for treating cancer comprises the following raw materials: 450 g of leech, 450 g of scorpion, 350 g of angelica, 350 g of donkey-hide gelatin, 350 g of astragalus root, 350 g of rhodiola rosea, 350 g of ground beetle, 350 g of nux vomica, 250 g of liquorice, 250 g of rhizoma polygonati, 250 g of wolfberry fruit, 250 g of tremella, 250 g of momordica cochinchinensis, 250 g of clam shell, 250 g of aspongopus, 250 g of mallow seed, 250 g of oyster, 250 g of gypsum, 250 g of gardenia, 150 g of fructus psoraleae, 150 g of radix rehmanniae, 150 g of semen acori graminei, 150 g of sword bean, 150 g of hawthorn, 150 g of rhizoma atractylodis, 150 g of poria cocos, 100 centipede, 150 g of rhizoma coptidis, 350 g of gastrodia elata, 100 g of white peony root, 50 g of polygonum cuspidatum, 50 g of field thistle, 150 g of sanguisorba, 30 g of fingered citron, 150 g of combined spicebush root, 30 g of cimicifugae, 50 g of kudzuvine root, 50 g of tetrandra root, 70 g of angelica dahurica, 100 g, 100 g of figwort root, 50 g of tree peony bark, 100 g of salvia miltiorrhiza, 50 g of black drynaria, 250 g of hairyvein agrimony, 50 g of sophora flower, 50 g of cacumen biotae, 50 g of lalang grass rhizome, 150 g of dipsacus root, 250 g of coix seed, 70 g of rhizoma alismatis, 150 g of fructus cannabis, 200 g of semen pharbitidis, 50 g of eucommia bark, 30 g of platycodon grandiflorum, 50 g of cornus officinalis, 100 g of semen cuscutae, 50 g of uncaria, 50 g of ligusticum wallichii, 150 g of curcuma zedoary, 150 g of rhizoma corydalis, 150 g of lycopodium clavatum, 50 g of cortex moutan, 50 g of radix peucedani, 50 g of radix stemonae, 50 g of cynanchum glaucescens, 30 g of semen brassicae, 150 g of corydalis, 50 g of almond, 30 g of ephedra, 50 g of notopterygium root, 50 g of magnolia flower.
Example 11
A medicine formula for treating cancer comprises the following raw materials: 500 g of leech, 500 g of scorpion, 400 g of angelica, 400 g of donkey-hide gelatin, 400 g of astragalus, 400 g of rhodiola rosea, 400 g of ground beetle, 400 g of nux vomica, 300 g of liquorice, 300 g of rhizoma polygonati, 300 g of wolfberry fruit, 300 g of tremella, 300 g of momordica cochinchinensis, 300 g of clam shell, 300 g of aspongopus, 300 g of malva verticillata, 300 g of oyster, 300 g of gypsum, 300 g of gardenia, 200 g of fructus psoraleae, 200 g of dried rhizome of rehmannia, 200 g of ovate tree seed, 200 g of sword bean, 200 g of hawthorn, 200 g of rhizoma atractylodis, 200 g of poria cocos, 150 g of centipede, 200 g of rhizoma coptidis, 400 g of rhizoma gastrodiae, 150 g of white peony root, 100 g of giant knotweed, 100 g of field thistle, 200 g of sanguisorba, 80 g of finger citron, 200 g of combined spicebush root, 80 g of black-bark, 100 g of cimicifugae rhizome, 100 g of kudzuvine root, 100 g of tetrandra root, 150 g of figwort root, 100 g of tree peony bark, 150 g of salvia miltiorrhiza, 100 g of black drynaria, 300 g of hairyvein agrimony, 100 g of sophora flower, 100 g of cacumen biotae, 100 g of lalang grass rhizome, 200 g of dipsacus root, 300 g of coix seed, 120 g of rhizoma alismatis, 200 g of fructus cannabis, 200 g of semen pharbitidis, 100 g of eucommia bark, 80 g of platycodon grandiflorum, 100 g of cornus officinalis, 150 g of semen cuscutae, 100 g of uncaria, 100 g of ligusticum wallichii, 200 g of curcuma zedoary, 200 g of rhizoma corydalis, 200 g of lycopodium clavatum, 100 g of cortex moutan, 100 g of radix peucedani, 100 g of radix stemonae, 100 g of rhizoma cynanchi, 80 g of semen brassicae, 200 g of corydalis, 100 g of almond, 80 g of ephedra, 100 g of notopterygium root, 100 g of magnolia flower, 80 g of.
Example 12
A medicine formula for treating cancer comprises the following raw materials: leech 550 g, scorpion 550 g, angelica 450 g, donkey-hide gelatin 450 g, astragalus 450 g, rhodiola 450 g, ground beetle 450 g, nux vomica 450 g, licorice 350 g, sealwort 350 g, wolfberry 350 g, tremella 350 g, momordica seed 350 g, clam shell 350 g, aspongopus 350 g, malva 350 g, oyster 350 g, gypsum 350 g, gardenia 350 g, psoralea fruit 250 g, dried rehmannia root 250 g, ovate seed 250 g, sword bean 250 g, haw 250 g, atractylodes 250 g, poria 250 g, centipede 200, Chinese lobelia 250 g, gastrodia tuber 450 g, white peony root 200 g, giant knotweed 150 g, field thistle 150 g, garden burnet 250 g, fingered citron 130 g, combined spicebush 250 g, cimicifuga rhizome 130 g, kudzuvine root 150 g, tetrandra root 150 g, dahurian angelica root 170 g, dandelion 200 g, uniflower swisscentaury 150 g, golden cypress 350 g, oldenlandia 250 g, scutellaria baicalensis 250 g, scutellaria 150 g, schisandra 150 g, phellodendron 150 g, coptis 150 g, 200 g of figwort root, 150 g of tree peony bark, 200 g of salvia miltiorrhiza, 150 g of black drynaria, 350 g of hairyvein agrimony, 150 g of sophora flower, 150 g of cacumen biotae, 150 g of lalang grass rhizome, 250 g of dipsacus root, 350 g of coix seed, 170 g of rhizoma alismatis, 250 g of fructus cannabis, 200 g of semen pharbitidis, 150 g of eucommia bark, 130 g of platycodon grandiflorum, 150 g of cornus officinalis, 200 g of semen cuscutae, 150 g of uncaria, 150 g of ligusticum wallichii, 250 g of curcuma zedoary, 250 g of corydalis tuber, 250 g of lycopodium clavatum, 50 g of cortex moutan, 150 g of peucedanum root, 150 g of radix stemonae, 150 g of rhizoma cynanchi, 130 g of semen brassicae, 250 g of corydalis tuber, 150 g of almond, 130 g of ephedra herb, 150 g of notopterygium root, 150 g of magnolia flower, 130.
Clinical trials on several cancer patients were conducted using the Chinese medicinal composition of examples 7 to 12. The clinical trial of the invention on cancer patients is shown in the following table:
clinical trial on several cancer patients the disease status statistical table (unit: case)
Figure BDA0002670885940000091
The invention makes curative effect observation for several months after clinical test on cancer patients in examples 7 to 12, and the specific statistics are as follows:
therapeutic effect observation statistical table after treatment
Figure BDA0002670885940000101
According to the statistical results, the medicine formula for treating the cancer has good effects on various malignant tumors, the significant efficiency and the total effective rate reach 100%, the average conversion rate is 83%, and the average stability rate is 40.3%; the formula of the invention is used for treating cancer and tumor, can lead the tumor to degenerate, and leads malignant tumor not to grow and transfer. The invention is not a unilateral disease medication, but a basic comprehensive medication for the five internal organs and six internal organs of the human body.
The medicine formula of the invention seems to be piled up, the compatibility is strict, according to the efficacy, the nature and the taste of the medicine, the channel tropism and the non-toxicity effect, and the treatment principle of the traditional Chinese medicine formula, the efficacy and the use value of the single medicine are greatly improved by the mutual reinforcement and the combined application of the medicines, and the medicine has the following efficacies: (1) clearing away heat and toxic material, eliminating toxic material, and resisting toxic material (controlling growth rate of cancer cells). (2) Removing blood stasis, resolving hard mass, softening and resolving hard mass, eliminating hard mass, removing calculus, and resisting blood coagulation. (3) Controlling blood and stopping bleeding, restricting the disorder of recklessly blood flow due to blood heat, and controlling the metastasis of cancer cells. (4) Invigorate spleen, induce diuresis, drain dampness, remove middle energizer, moisten intestines, relieve constipation, and reduce blood heat to transform tumor. (5) Reduce blood fat, and make tumor lose the vigor of life accompanying with the tumor. In addition, the formula of the invention has the main components contained in the six famous and precious traditional Chinese medicines, namely the cordyceps sinensis, the saffron, the musk, the pangolin, the antelope horn and the pilose antler, but the six medicines are not used in the invention, so the economic value of the medicine is reduced, and the wild animals such as the pangolin are protected.
Further, the pharmaceutical composition of the present invention is prepared according to the mixture ratio of the above examples 7 to 12, and the following points should be noted:
(1) the traditional Chinese medicines are prepared according to the formula quantity of the invention by manufacturers, and then are processed into small granules, granules and tablets, and the granules are divided into small packages, wherein each package contains 10 g of the traditional Chinese medicine. One packet for an adult once, four times a day; the old can be packed three times a day or half a bag each time; one package of the children can be taken for three times.
(2) 400 g of nux vomica is used as a ministerial drug, the total weight of the formula is 17000 g, 1700 small bags are arranged according to 10 g of each bag, and each small bag accounts for 0.24 g of nux vomica, which is lower than the minimum dosage of nux vomica. The actual dose of nux vomica is 0.3-0.6 g each time. Is suitable for safe medication.
(3) When the medicine is taken, adverse reactions are avoided temporarily. Avoiding: spicy hot food. The prescription forms traditional Chinese medicine granules or electuary, and is suitable for early, middle and late treatment of tumor patients.
(4) The traditional Chinese medicine granules or electuary in the prescription can be used for treating chronic laryngitis, and the cure rate is high.
(5) The patients with malignant tumor should not eat high-nutrition food and spicy and hot food during the administration period.
As can be seen from the data statistical table, the formula of the invention has good effect on various malignant tumors, so that the malignant tumors cannot grow and metastasize.
Clinical validation and analysis:
since the 21 st century, China has further realized historically inherited traditional Chinese medicines, and more emphasis is placed on the research and innovation work of traditional Chinese medicines. Therefore, the invention develops a traditional Chinese medicine formula for treating cancer, so as to control the growth and metastasis of cancer, relieve the pain of cancer patients, promote the technical development of treating malignant tumors in China, almost eliminate metastasis of cancer patients and cure patients who are treated early; the cancer patient can control the cancer cells not to transfer by taking the traditional Chinese medicine after the operation; the life is prolonged. Thereby advancing the traditional medicine.
In recent years, the inventor treats hundreds of people with cancer by using the prescription of the invention, and twelve cancer patients reach the Chongqing Fengjie traditional Chinese medicine research institute company of the inventor, but most of the people are in the final stage, and are under the policy of each hospital, and the patients only come to our places, so that the inventor definitely knows the four obvious effects of the invention in the treatment. The tumor is detected in a hospital, the data is small, and people do not have symptom reaction, and after eating the granules prepared by the formula disclosed by the invention, the tumor degeneration is completed, the tumor is consolidated, and the disease is cured. After the patient is examined that the tumor is large in hospital and the patient is cured after the patient is cut, the cancer cells are controlled not to transfer after the patient eats the granules prepared by the formula, and the cancer cells are examined by the hospital to completely disappear. The cancer is already metastatic or several cancers, which can only prolong the life time of a patient for months or years and relieve the pain of the patient. The traditional Chinese medicine granules prepared by the formula of the invention are taken by people who eat more troxeritis and morphine instead of people who are about to die of cancer patients and cannot get up in the daytime or sleep at night, and the life of the traditional Chinese medicine granules can be prolonged by several months after the traditional Chinese medicine granules are taken by the inventor instead of the medicine granules for treating lumbar intervertebral disc and rheumatism rheumatoid applied by the inventor in 2019, 4, 28 and 28.
Clinical verification data:
the following are typical cases in the statistical data, all treated by the traditional Chinese medicine granules prepared by the formula of the invention:
first, old a certain person, woman, 62 years old; cerebral aneurysm, tetany of the limbs, blurred vision; after the operation is performed in a hospital in Chongqing in 2018 and 9 months, postoperative symptoms are not changed, treatment is invalid by multiple parties, treatment is sought in 22 days in 4 and 4 months in 2019, the disease condition is improved after taking the traditional Chinese medicine granules prepared by the formula for ten days, the symptoms disappear gradually, the medicine is stopped to go to the hospital for examination and diagnosis after continuously taking the medicine for 9 months, and a doctor informs that the disease is completely cured.
II, in certain absenteeism, female, age 48; pituitary gland tumor and rhinitis cancer, headache, nose pain, eye swelling pain, numbness and pain of hands and feet; the big hospital can not cure the disease, the situation is proved by the fact that the person is difficult to sit on a car and is seriously ill in 2018, 12 and 2 days, the person mails the traditional Chinese medicine particles prepared by the formula to the person on the day, the person slowly gets better after taking the medicine for 1 month continuously, the person does not feel painful after taking the medicine for a long time, and then takes the medicine intermittently, so that the body is healthy at present.
Thirdly, aging a certain one, male, 42 years old; pancreatic cancer; the patient is opened at 28 days in 2016 and relapses in 10 months in 2016; the disease condition is gradually improved by taking the traditional Chinese medicine granules prepared by the formula of the invention in 2017 for 1 month and 12 days, and the traditional Chinese medicine granules are taken half a year later. The patient is examined in a large hospital and cured. When I call to visit I in 2020 on 8/1, the health of the person is known.
Fourth, somebody, male, age 36, lung and brain cancer; the Chongqing hospitals and Shanghai hospitals are ineffective in treatment, the patients are recommended to stop high-nutrition food and spicy and hot food in 16 days 8 and 2019, and then the traditional Chinese medicine granules prepared by the formula are taken for two months, the patients go to the hospitals for examination and diagnosis, the tumor is reduced by 0.4cm, the tumor continues to degenerate after the patients are continuously taken for a period of time, and the treatment is still performed at present.
Fifthly, certain Wei, female, age 68, lung adenocarcinoma; expectoration, discomfort in the heart; the diagnosis is confirmed in a certain hospital in Chongqing in 2019 and 5 months, the patient is treated in the 7 th day in 2019 and 11 months, the patient takes the traditional Chinese medicine granules prepared by the formula of the invention for three months, the traditional Chinese medicine granules go to a large hospital for examination, the tumor is controlled, the traditional Chinese medicine granules do not grow up or shrink, but the symptoms disappear, the normal life can be realized, and the traditional Chinese medicine granules are still in treatment at present.
Sixthly, a certain Guo and a female are 48 years old; thyroid cancer, lymph node cancer; when the doctor is asked at 6 days 12 and 6 months in 2019 and the traditional Chinese medicine particles prepared by the formula are eaten for two months, the tumor is reduced from 5.2 x 2.7cm to 2.9 x 1.8cm, lymph nodes disappear, and the treatment is consolidated at present.
Seventhly, some Liu, male, age 34; malignant tumor, malignant rhinitis cancer, malignant lung cancer, malignant liver tumor, bone malignant tumor, and tumor anemia; the diagnosis is confirmed in a certain hospital in Ganzhou city in 4 and 17 days in 2020, no cure is expected by self, through introduction of people, the treatment is carried out in 24 days in 4 and 4 months in 2020, the traditional Chinese medicine particles prepared by the formula of the invention are continuously taken for one month, then the observation and diagnosis are carried out, the tumor is reduced, other abnormal indexes are gradually recovered to be normal, the deterioration is not caused until now, and the treatment is consolidated at present.
Eighthly, malignant tumor of certain mammary gland, female, age 48 and right mammary gland; the swelling 3.1 x 1.8 x 1.4mm, after she was discharged from Chongqing hospital after operation, she took three more months from 3 months and 19 days in 2019, and then was examined to get the disease cured, and after stopping taking the medicine, she was healthy.
Jiu, Dang, male, 50 years old; bronchogenic carcinoma, small cell carcinoma, with right pleural metastases, portulaca metastasis, thrombocytosis, low blood pressure; the Chinese medicinal granules are controlled to eliminate various symptoms of chest pain, throat discomfort and foot and hand weakness after the examination and diagnosis in a Chongqing hospital in 6 and 15 days in 2019 and the medical seeking in 21 days in 6 and 21 days in 2019, so that the health of people is strengthened.
Tenthly, somebody wu, women, 56 years old; esophageal tumor, cell tumor metastasis, abnormal cervical tube signal shadow size of about 22 x 6mm, arm pain, and even-burst hand pain; the traditional Chinese medicine granules prepared by the formula of the invention are taken in 10 days 2 month in 2020, the symptoms are improved after the traditional Chinese medicine granules are eaten, and the traditional Chinese medicine granules are controlled.
Eleven, Zheng, male, 55 years old; liver tumor nodular carcinoma, 3.8cm in size, with thrombocytopenia; after the traditional Chinese medicine granules prepared by the formula are taken in three or more months in the future of 28 days 1 month in 2020, tumors are controlled, and the growth and the contraction are avoided, so that the platelets are recovered to be normal, and the normal life is recovered.
Twelve and king certain, male, 62 years old; intracranial aneurysm, postoperative change, enlarged occipital cisterna, visible size of 6.4 x 1.8cm density shadow, headache, dizziness, thirst and water; the patient is saved and treated in 20 days 3 and 20 months in 2020, and when the traditional Chinese medicine particles prepared by the formula are eaten for ten days, all symptoms are eliminated, the patient is taken for two months to get a heavy celebration and a large examination diagnosis, the cancer and tumor are controlled, the cancer and tumor do not grow up or shrink, no symptom occurs at present, and the patient is still under consolidation control.
Thirteen, for treating certain, woman, 66 years old, liver tumor sarcoidosis, with a size of about 26 x 3.0cm, upset heart, headache, dizziness, abdominal distention, vomiting; when the Chinese medicinal granules prepared by the formula are taken in the place of 5-15 days in 2020, various symptoms are gradually eliminated, the belly is not swollen, and the Chinese medicinal granules are still in the process of taking medicine.
Fourteen, some on the root of common Bupleurum, male, 64 years old; lung cancer, squamous cell carcinoma, thrombocytopenia, expectoration, weakness of the feet, nasal bleeds, stomach distension, liver positivity, constipation; in a certain large hospital in Sichuan, the number of platelets is 36 at most, sometimes is less than a few, and the platelets can not rise after injection in the hospital every day for ten days, after eating the traditional Chinese medicine granules prepared by the formula of the invention for several days, the inventor notifies him that all symptoms are improved after checking that the platelets are rising 294; after the medicine is taken for a plurality of months, the medicine is controlled and is taken.
Fifteen, certain in spacious, female, age 47, meningioma; patients have dizziness, headache and pain and numbness of hands and feet, are afraid of falling down when walking, have illusion of sleeping, seem to sink from upstairs to downstairs, sometimes the feet are not opened when stepping suddenly, and both legs are soft; when a call comes in 19 days in 5 months in 2020, treatment is requested, because a certain sitting car is difficult and seriously ill, the Chinese medicinal granules prepared by the formula are mailed to the person on the day, the disease condition is changed greatly after the person takes the medicine for one month, the call requests to send the medicine again, the symptoms are eliminated after the person takes the medicine for several months, and the treatment is still under consolidated control at present.
Sixthly, Dun, women and students; chronic laryngitis for more than 2 months, susceptibility to common cold and uncomfortable throat, transfusion treatment and aggravation of disease; the traditional Chinese medicine granules prepared by the formula are taken in the local place 4 and 6 days in 2019, and the traditional Chinese medicine granules are cured after being taken for 6 days, so that no relapse occurs.
Seventeen, somebody of Tang, male, age 61; lung cancer, 5.2 x 3.9cm of lumps in right lower lobe of lung, high density axillary lymph nodes in left upper lobe of lung, partial swelling, and ineffectiveness after western medicine; the diagnosis is confirmed in a certain hospital in Guangan City in 7 and 17 months in 2019, and the lung swelling mass is enlarged and axillary lymph nodes are partially enlarged after the repeated examination in 5 and 14 months in 2019 without operation; in 20 days after 8 months and 8 months in 2019, after the traditional Chinese medicine particles prepared by the formula are taken for several months, the tumor is not enlarged and diffused, the tumor is controlled, no symptom appears, the body is healthy at present, and the life is recovered to be normal.
The cancer cases show that the medicine formula for treating the cancer is suitable for treating cancer patients in early, middle and late stages, and has the effect of controlling the growth and metastasis of cancer cells beyond the effect which can not be achieved by western medicines.
The above-mentioned embodiments are further described in detail for the purpose of illustrating the invention, and it should be understood that the above-mentioned embodiments are only exemplary embodiments of the invention and are not intended to limit the invention, and any modifications, equivalent substitutions, improvements and the like made within the spirit of the invention should be included in the scope of the invention.

Claims (10)

1. The medicine formula for treating the cancer is characterized by comprising the following raw materials: 450-550 g of leech, 450-550 g of scorpion, 350-450 g of angelica sinensis, 350-450 g of donkey-hide gelatin, 350-450 g of astragalus membranaceus, 350-450 g of rhodiola rosea, 350-450 g of ground beetle, 350-450 g of nux vomica, 250-350 g of liquorice, 250-350 g of rhizoma polygonati, 250-350 g of wolfberry fruit, 250-350 g of tremella, 250-350 g of momordica cochinchinensis, 250-350 g of clam shell, 250-350 g of aspongopus, 250-350 g of cluster mallow seed, 250-350 g of oyster, 250-350 g of gypsum, 250-350 g of gardenia, 150-250 g of fructus psoraleae, 150-250 g of radix rehmanniae, 150-250 g of Concha arcae, 150-250 g of sword bean, 150-250 g of hawthorn, 150-250 g of rhizoma atractylodis, 150-250 g of poria cocos, 100-200 centipedes, 150-250 g of rhizoma gastrodiae and 350.
2. The pharmaceutical formulation for treating cancer according to claim 1, further comprising the following pharmaceutical raw materials: 100-200 g of white peony root, 50-150 g of giant knotweed, 50-150 g of field thistle, 150-250 g of garden burnet, 30-130 g of fingered citron, 150-250 g of radix linderae, 30-130 g of cimicifugae foetidae, 50-150 g of kudzu-vine root, 50-150 g of radix stephaniae tetrandrae, 70-170 g of angelica dahurica, 100-200 g of dandelion, 50-150 g of uniflower swisscentaury root, 250-350 g of wild buckwheat rhizome, 150-250 g of herba scutellariae barbatae, 150-250 g of oldenlandia diffusa, 50-150 g of scutellaria baicalensis, 50-150 g of golden cypress.
3. The pharmaceutical formulation for treating cancer according to claim 2, further comprising the following pharmaceutical raw materials: 50-150 g of Japanese thistle herb, 100-200 g of figwort root, 50-150 g of cortex moutan, 100-200 g of salvia miltiorrhiza, 50-150 g of herba agrimoniae, 50-150 g of sophora flower, 50-150 g of cacumen biotae, 50-150 g of rhizoma imperatae and 150-250 g of dipsacus root.
4. The pharmaceutical formulation for treating cancer according to claim 3, further comprising the following pharmaceutical raw materials: 250-350 g of coix seed, 70-170 g of rhizoma alismatis, 150-250 g of fructus cannabis, 200 g of semen pharbitidis, 50-150 g of eucommia bark, 30-130 g of platycodon grandiflorum and 50-150 g of cornus officinalis.
5. The pharmaceutical formulation for treating cancer according to claim 1, comprising the following raw materials: 450 g of leech, 450 g of scorpion, 350 g of angelica, 350 g of donkey-hide gelatin, 350 g of astragalus, 350 g of rhodiola rosea, 350 g of ground beetle, 350 g of nux vomica, 250 g of liquorice, 250 g of rhizoma polygonati, 250 g of medlar, 250 g of tremella, 250 g of momordica cochinensis, 250 g of clam shell, 250 g of aspongopus, 250 g of chingma abutilon seed, 250 g of oyster, 250 g of gypsum, 250 g of gardenia, 150 g of fructus psoraleae, 150 g of radix rehmanniae, 150 g of concha arcae, 150 g of sword bean, 150 g of hawthorn, 150 g of rhizoma atractylodis, 150 g of poria cocos, 100 centipedes, 150 g of rhizoma gastrodiae and.
6. The pharmaceutical formulation for treating cancer according to claim 1, comprising the following raw materials: 500 g of leech, 500 g of scorpion, 400 g of angelica, 400 g of donkey-hide gelatin, 400 g of astragalus, 400 g of rhodiola rosea, 400 g of ground beetle, 400 g of nux vomica, 300 g of liquorice, 300 g of rhizoma polygonati, 300 g of medlar, 300 g of tremella, 300 g of momordica cochinensis, 300 g of clam shell, 300 g of aspongopus, 300 g of malva verticillata, 300 g of oyster, 300 g of gypsum, 300 g of gardenia, 200 g of fructus psoraleae, 200 g of radix rehmanniae, 200 g of concha arcae, 200 g of sword bean, 200 g of hawthorn, 200 g of rhizoma atractylodis, 200 g of poria cocos, 150 centipedes, 200 g of rhizoma gastrodiae and 400 g.
7. The pharmaceutical formulation for treating cancer according to claim 1, comprising the following raw materials: 550 g of leech, 550 g of scorpion, 450 g of angelica, 450 g of donkey-hide gelatin, 450 g of astragalus, 450 g of rhodiola rosea, 450 g of ground beetle, 450 g of nux vomica, 350 g of liquorice, 350 g of rhizoma polygonati, 350 g of medlar, 350 g of tremella, 350 g of momordica cochinensis, 350 g of clam shell, 350 g of aspongopus, 350 g of chingma abutilon seed, 350 g of oyster, 350 g of gypsum, 350 g of gardenia, 250 g of fructus psoraleae, 250 g of radix rehmanniae, 250 g of concha arcae, 250 g of sword bean, 250 g of hawthorn, 250 g of rhizoma atractylodis, 250 g of poria cocos, 200 centipedes, 250 g of rhizoma gastrodiae and.
8. The pharmaceutical formulation for treating cancer according to claim 4, comprising the following raw materials: 450 g of leech, 450 g of scorpion, 350 g of angelica, 350 g of donkey-hide gelatin, 350 g of astragalus root, 350 g of rhodiola rosea, 350 g of ground beetle, 350 g of nux vomica, 250 g of liquorice, 250 g of rhizoma polygonati, 250 g of wolfberry fruit, 250 g of tremella, 250 g of momordica cochinchinensis, 250 g of clam shell, 250 g of aspongopus, 250 g of mallow seed, 250 g of oyster, 250 g of gypsum, 250 g of gardenia, 150 g of fructus psoraleae, 150 g of radix rehmanniae, 150 g of semen acori graminei, 150 g of sword bean, 150 g of hawthorn, 150 g of rhizoma atractylodis, 150 g of poria cocos, 100 centipede, 150 g of rhizoma coptidis, 350 g of gastrodia elata, 100 g of white peony root, 50 g of polygonum cuspidatum, 50 g of field thistle, 150 g of sanguisorba, 30 g of fingered citron, 150 g of combined spicebush root, 30 g of cimicifugae, 50 g of kudzuvine root, 50 g of tetrandra root, 70 g of angelica dahurica, 100 g, 100 g of figwort root, 50 g of tree peony bark, 100 g of salvia miltiorrhiza, 50 g of black meadowrue root, 250 g of hairyvein agrimony, 50 g of sophora flower, 50 g of cacumen biotae, 50 g of root of hairy melastoma, 150 g of dipsacus root, 250 g of coix seed, 70 g of rhizoma alismatis, 150 g of fructus cannabis, 200 g of semen pharbitidis, 50 g of eucommia bark, 30 g of platycodon root and 50 g of cornus officinalis.
9. The pharmaceutical formulation for treating cancer according to claim 4, comprising the following raw materials: 500 g of leech, 500 g of scorpion, 400 g of angelica, 400 g of donkey-hide gelatin, 400 g of astragalus, 400 g of rhodiola rosea, 400 g of ground beetle, 400 g of nux vomica, 300 g of liquorice, 300 g of rhizoma polygonati, 300 g of wolfberry fruit, 300 g of tremella, 300 g of momordica cochinchinensis, 300 g of clam shell, 300 g of aspongopus, 300 g of malva verticillata, 300 g of oyster, 300 g of gypsum, 300 g of gardenia, 200 g of fructus psoraleae, 200 g of dried rhizome of rehmannia, 200 g of ovate tree seed, 200 g of sword bean, 200 g of hawthorn, 200 g of rhizoma atractylodis, 200 g of poria cocos, 150 g of centipede, 200 g of rhizoma coptidis, 400 g of rhizoma gastrodiae, 150 g of white peony root, 100 g of giant knotweed, 100 g of field thistle, 200 g of sanguisorba, 80 g of finger citron, 200 g of combined spicebush root, 80 g of black-bark, 100 g of cimicifugae rhizome, 100 g of kudzuvine root, 100 g of tetrandra root, 150 g of figwort root, 100 g of tree peony bark, 150 g of salvia miltiorrhiza, 100 g of black meadowrue root, 300 g of hairyvein agrimony, 100 g of sophora flower, 100 g of cacumen biotae, 100 g of root of hairy melastoma, 200 g of dipsacus root, 300 g of coix seed, 120 g of rhizoma alismatis, 200 g of fructus cannabis, 200 g of semen pharbitidis, 100 g of eucommia bark, 80 g of platycodon grandiflorum and 100 g of cornus officinalis.
10. The pharmaceutical formulation for treating cancer according to claim 4, comprising the following raw materials: leech 550 g, scorpion 550 g, angelica 450 g, donkey-hide gelatin 450 g, astragalus 450 g, rhodiola 450 g, ground beetle 450 g, nux vomica 450 g, licorice 350 g, sealwort 350 g, wolfberry 350 g, tremella 350 g, momordica seed 350 g, clam shell 350 g, aspongopus 350 g, malva 350 g, oyster 350 g, gypsum 350 g, gardenia 350 g, psoralea fruit 250 g, dried rehmannia root 250 g, ovate seed 250 g, sword bean 250 g, haw 250 g, atractylodes 250 g, poria 250 g, centipede 200, Chinese lobelia 250 g, gastrodia tuber 450 g, white peony root 200 g, giant knotweed 150 g, field thistle 150 g, garden burnet 250 g, fingered citron 130 g, combined spicebush 250 g, cimicifuga rhizome 130 g, kudzuvine root 150 g, tetrandra root 150 g, dahurian angelica root 170 g, dandelion 200 g, uniflower swisscentaury 150 g, golden cypress 350 g, oldenlandia 250 g, scutellaria baicalensis 250 g, scutellaria 150 g, schisandra 150 g, phellodendron 150 g, coptis 150 g, 200 g of figwort root, 150 g of tree peony bark, 200 g of salvia miltiorrhiza, 150 g of black meadowrue root, 350 g of hairyvein agrimony, 150 g of sophora flower, 150 g of cacumen biotae, 150 g of root of hairy melastoma, 250 g of dipsacus root, 350 g of coix seed, 170 g of rhizoma alismatis, 250 g of fructus cannabis, 200 g of semen pharbitidis, 150 g of eucommia bark, 130 g of platycodon root and 150 g of cornus officinalis.
CN202010932961.1A 2020-09-08 2020-09-08 Medicine composition for treating cancer Pending CN111920909A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010932961.1A CN111920909A (en) 2020-09-08 2020-09-08 Medicine composition for treating cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010932961.1A CN111920909A (en) 2020-09-08 2020-09-08 Medicine composition for treating cancer

Publications (1)

Publication Number Publication Date
CN111920909A true CN111920909A (en) 2020-11-13

Family

ID=73309298

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010932961.1A Pending CN111920909A (en) 2020-09-08 2020-09-08 Medicine composition for treating cancer

Country Status (1)

Country Link
CN (1) CN111920909A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112472737A (en) * 2020-12-04 2021-03-12 东莞市中医院 Traditional Chinese medicine composition for treating prostate cancer and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108653671A (en) * 2018-06-28 2018-10-16 辽宁传明健康产业有限公司 A kind of anticancer drug and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108653671A (en) * 2018-06-28 2018-10-16 辽宁传明健康产业有限公司 A kind of anticancer drug and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
张民庆，龚惠明: "《抗肿瘤中药的临床应用》", 30 September 1998, 人民卫生出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112472737A (en) * 2020-12-04 2021-03-12 东莞市中医院 Traditional Chinese medicine composition for treating prostate cancer and preparation method thereof

Similar Documents

Publication Publication Date Title
CN1562160A (en) Composite medicine for treating hepatitis B complication
CN103893722A (en) Traditional Chinese medicinal composition for treating solar dermatitis and preparation method thereof
CN105535577A (en) Medicament to reduce the side effects of chemotherapy for tumor patient
CN101224290B (en) Chinese traditional medicine for treating breast nodules and preparing method thereof
CN111920909A (en) Medicine composition for treating cancer
CN103041255B (en) Chinese materia medica preparation for curing swollen sore throat and respiratory tract infection of children
CN104888157A (en) Traditional Chinese medicine preparation for treating hysteromyoma and preparation method thereof
CN104873926A (en) Traditional Chinese medicine preparation for treating diarrhea as well as preparation method and application of traditional Chinese medicine preparation
CN105521332A (en) Traditional Chinese medicinal composition for treating anal fissure, and preparation method and application thereof
CN104825768A (en) Traditional Chinese medicine oral liquid for treating scrofula and preparation method thereof
CN116350731B (en) Formula for clearing heat, removing dampness and relieving arthralgia as well as preparation and application thereof
CN113855778B (en) Traditional Chinese medicine for treating spleen-kidney yang deficiency obstinate phlegm blood type esophageal cancer
CN109200250A (en) A kind of Chinese medicine composition and preparation method thereof for treating breast cancer
CN111110782B (en) Application of traditional Chinese medicine composition in preparation of medicine for treating cold
CN102626506B (en) Traditional Chinese medicine for curing seroperitoneum
CN101721639B (en) Traditional Chinese medicine composition for treating gynecological ovarian cyst and preparation method thereof
CN106334155A (en) Traditional Chinese medicine composition for treating arterial thyromegaly and preparation method thereof
CN104922595A (en) Traditional Chinese medicinal preparation for herpes zoster and preparation method thereof
CN115300595A (en) Guxindan capsule
CN104800724B (en) Improve the medicine of toxicity after chemotherapy of tumors
CN112717023A (en) Traditional Chinese medicine compound for treating lumbar intervertebral disc protrusion and preparation method
CN104225506A (en) Medicinal preparation for treating thrombocytopenia after chemotherapy
CN114099618A (en) Traditional Chinese medicine composition for treating cervical spondylosis and preparation method and application thereof
CN115634265A (en) Traditional Chinese medicine composition for clearing damp and conditioning damp-heat constitution and medicated diet thereof
CN114306465A (en) Traditional Chinese medicine composition for treating kidney-yang deficiency type constipation, preparation and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20210719

Address after: 404600 No. 31, Pinghu street, Yong'an street, Fengjie County, Chongqing

Applicant after: Chongqing Fengjie Kuang Fuyong Institute of traditional Chinese Medicine

Address before: 404600 No. 31, Pinghu street, Yong'an street, Fengjie County, Chongqing

Applicant before: Chongqing Fengjie Kuang Fu Yong Institute of traditional Chinese Medicine Co.,Ltd.

TA01 Transfer of patent application right